This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Johns Hopkins University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: William Schubert: Innovator in Neurodegenerative Disease Treatment
Introduction
William Schubert is a notable inventor based in Wuppertal, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neurodegenerative diseases. His innovative work has led to the development of compounds that hold promise for addressing critical health challenges.
Latest Patents
William Schubert holds a patent for "Substituted 4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)thiophene-2-carboxamide derivatives and use thereof." This patent includes compounds that are useful for the treatment and prevention of neurodegenerative diseases or disorders, including ophthalmological neurodegenerative disorders. The patent outlines methods of using and making these compounds, showcasing their potential therapeutic applications.
Career Highlights
William Schubert is affiliated with Johns Hopkins University, where he continues to engage in research and development. His work is characterized by a commitment to advancing medical science and improving patient outcomes through innovative solutions.
Collaborations
He has collaborated with esteemed colleagues, including Byung-Jin Kim and Hartmut Schirok. These partnerships have contributed to the advancement of research in the field of neurodegenerative diseases.
Conclusion
William Schubert's contributions to the field of pharmaceuticals, particularly in neurodegenerative disease treatment, highlight his role as an influential inventor. His patented compounds represent a significant step forward in medical research and offer hope for future therapeutic advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
